Search Results

Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.

China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.

Bruker Introduces the Ingenious Novel ‘ Triceratops ’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024.

BostonGene announced today that it will participate in and present at the SLAS2024 International Conference and Exhibition on February 3 - 7, 2024, in Boston, MA.

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.

A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.

Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held in Boston from February 3-7 in booth #408.

Zealand Pharma A/S announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion recommending granting marketing authorization for dasiglucagon solution for injection in the treatment of severe hypoglycemia in adults, adolescents, and children aged 6 years and over with diabetes mellitus.